Whole-body biodistribution and estimation of radiation-absorbed doses of the dopamine D1 receptor radioligand 11C-NNC 112 in humans

VL Cropley, M Fujita, JL Musachio, J Hong… - Journal of Nuclear …, 2006 - Soc Nuclear Med
The present study estimated radiation-absorbed doses of the dopamine D1 receptor
radioligand [11C]((+)-8-chloro-5-(7-benzofuranyl)-7-hydroxy-3-methyl-2, 3, 4, 5-tetrahydro-1 …

11C-and 76Br-labelled NNC 22-0010, selective dopamine D1 receptor radioligands for PET

C Foged, C Halldin, C Loc'h, B Mazière… - Nuclear medicine and …, 1996 - Elsevier
NNC 22-0010 is a new dopamine antagonist with a high affinity and selectivity for D1
receptors in vitro. NNC 22-0010 has both an N-methyl group and a bromine, which allows …

Biodistribution and radiation dosimetry of the dopamine D2 ligand 11C-raclopride determined from human whole-body PET

M Slifstein, DR Hwang, D Martinez… - Journal of Nuclear …, 2006 - Soc Nuclear Med
Whole-body radiation dosimetry of 11C-raclopride was performed in healthy human
volunteers. Methods: Subjects (n= 6) were scanned with PET. Subjects received single …

[11C] NNC 22-0215, a metabolically stable dopamine D1 radioligand for PET

C Foged, C Halldin, CG Swahn, N Ginovart… - Nuclear medicine and …, 1998 - Elsevier
NNC 22-0215 has been found to be a metabolically stable dopamine D1 antagonist with
high affinity and selectivity for D1 receptors in vitro. We prepared [11C] NNC 22-0215 with a …

Biodistribution and radiation dosimetry in humans of [11C] FLB 457, a positron emission tomography ligand for the extrastriatal dopamine D2 receptor

Y Kimura, H Ito, T Shiraishi, H Fujiwara… - Nuclear medicine and …, 2014 - Elsevier
Abstract Purpose [11 C] FLB 457, a radioligand with very high affinity and selectivity for
dopamine D 2/3 receptors, is used to measure receptor binding in extrastriatal regions …

18F-MCL-524, an 18F-labeled dopamine D2 and D3 receptor agonist sensitive to dopamine: a preliminary PET study

SJ Finnema, V Stepanov, R Nakao… - Journal of Nuclear …, 2014 - Soc Nuclear Med
PET has been used to examine changes in neurotransmitter concentrations in the living
brain. Pioneering PET studies on the dopamine system have used D2 and D3 receptor …

Human biodistribution and dosimetry of the SPECT D2 dopamine receptor radioligand [123I] IBF

CH van Dyck, JP Seibyl, JB Stubbs, S Zoghbi… - Nuclear medicine and …, 1996 - Elsevier
The research discussed in this article aimed to characterize better the biodistribution,
excretion and radiation dosimetry of the single photon emission computed tomography …

Human biodistribution and dosimetry of the D2/3 agonist 11C-N-propylnorapomorphine (11C-NPA) determined from PET

CM Laymon, NS Mason, WG Frankle… - Journal of Nuclear …, 2009 - Soc Nuclear Med
We measured the whole-body distribution of intravenously injected 11C-N-
propylnorapomorphine (11C-NPA), a dopamine agonist PET tracer, in human subjects and …

[PDF][PDF] Biodistribution and radiation dosimetry of radioiodinated-SCH 23982, a potential dopamine D-1 receptor imaging agent

CM Thonoor, MW Couch, DM Greer… - Journal of nuclear …, 1988 - Soc Nuclear Med
MATERIALS AND METhODS Radiopharmaceutical Iodine-125 SCH 23982 (R-(+)-8-['251]
iodo-7-hydroxy 2, 3, 4, 5-tetrahydro-3-methyl-5-phenyl-lH-3-benzazepine) in 50% n …

(+)-[76Br] A-69024: a non-benzazepine radioligand for studies of dopamine D1 receptors using PET

M Kassiou, C Loc'h, M Bottlaender, K Mardon… - Nuclear medicine and …, 2002 - Elsevier
(+)-[76Br] A-69024 is a specific and enantioselective dopamine D1 receptor radioligand. The
Bmax of (+)-[76Br] A-69024 measured in vitro on rat striatum membranes was 320±25 …